Related Experiment Video
Updated: Jun 14, 2026
07:52
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Calcific uremic arteriolopathy--the argument for hyperbaric oxygen and sodium thiosulfate
Natasha M Rogers1, P Toby H Coates
1Department of Nephrology and Transplantation Services, The Queen Elizabeth Hospital, Woodville, South Australia, Australia.
Seminars in Dialysis
|March 25, 2010
Summary
Calcific uremic arteriolopathy (CUA), a rare kidney disease complication causing painful wounds, may be treated with hyperbaric oxygen and sodium thiosulfate. These therapies aid wound healing and reduce vascular calcification, improving patient outcomes.
Area of Science:
- Nephrology
- Dermatology
- Vascular Medicine
Background:
- Calcific uremic arteriolopathy (CUA) is a rare but severe complication in end-stage kidney disease patients.
- CUA presents with medial calcification, panniculitis, and dermal necrosis, leading to painful, non-healing wounds.
- High mortality rates (up to 80%) are primarily attributed to sepsis.
Purpose of the Study:
- To review recent case reports on adjuvant therapies for Calcific Uremic Arteriolopathy.
- To highlight the potential benefits of hyperbaric oxygen (HBO) and sodium thiosulfate in CUA treatment.
Main Methods:
- Review of recent case reports detailing the use of hyperbaric oxygen (HBO) and sodium thiosulfate.
- Analysis of the proposed mechanisms of action for both HBO and sodium thiosulfate in CUA.
Main Results:
- Hyperbaric oxygen (HBO) enhances oxygen delivery, promoting growth factors, neoangiogenesis, and collagen synthesis for wound healing.
- Sodium thiosulfate chelates calcium ions, reducing vascular calcification and providing rapid pain relief with slower regression of calcific nodules.
- Both HBO and sodium thiosulfate show significant success as adjuvant therapies for CUA.
Conclusions:
- Aggressive treatment of Calcific Uremic Arteriolopathy is advocated.
- Hyperbaric oxygen and sodium thiosulfate represent promising adjuvant therapies for CUA.
- Further research into optimizing CUA treatment strategies is warranted.
Related Concept Videos
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.